Will Mastek’s 8.3% order backlog growth make it a mid-cap IT outlier in FY26?

Mastek Limited (NSE: MASTEK; BSE: 523704) has reported an 8.3% year-on-year rise in its 12-month order backlog, reaching ₹2,347.9 crore as of June 30, 2025, according to the company’s Q1 FY26 investor presentation. The Indian digital engineering and cloud transformation specialist has consistently expanded its footprint in the UK and Europe, which now accounts for nearly two-thirds of its revenue. The order pipeline, supported by strategic public sector and healthcare contracts, is driving optimism around whether Mastek can outperform other mid-cap IT service providers in FY26.

How does Mastek’s order backlog growth compare with peers, and what drives its momentum in public sector and healthcare verticals?

The order backlog expansion highlights Mastek’s steady deal flow, particularly in high-value government and healthcare segments. Key wins during the quarter included a one-year extension to manage a UK-based national biometrics platform for a central government agency, a strategic engagement with a UK-based central banking institution to modernize data analytics for monetary policy, and a healthcare regulatory platform deal built on Microsoft Dynamics CRM. These contracts underscore the company’s strong positioning as a trusted digital transformation partner for regulated industries.

Comparatively, other mid-cap IT players have reported slower backlog or pipeline growth. Persistent Systems, for example, is seeing double-digit revenue growth but continues to rely heavily on BFSI and product engineering, while Coforge’s recent guidance suggests single-digit order inflow growth, focused largely on travel and financial services. Mastek’s 8.3% growth places it ahead of many mid-cap peers in terms of sustained demand visibility, particularly because public sector contracts are considered more resilient in volatile markets.

The UK and Europe markets remain crucial, contributing 63.8% of Mastek’s Q1 FY26 revenue. Healthcare and life sciences accounted for 25% of quarterly revenue, reinforcing the impact of Oracle Cloud and AI-led projects. The company’s emphasis on Oracle Cloud and ADOPT.ai for back-office modernization in healthcare and life sciences has helped secure repeat and incremental deals. According to the investor presentation, early results from AI-enabled modernization projects, such as a UK-based EdTech client’s 60% effort savings and 98.7% functional parity in application migration, are further strengthening deal conversion rates.

What makes the order backlog important for investors tracking Mastek’s performance in FY26?

A healthy order backlog offers revenue visibility and reduces dependence on short-term client acquisitions. Analysts tracking the mid-cap IT sector believe that Mastek’s backlog growth, supported by fixed-price contracts making up 60.3% of revenue, reflects predictable cash flows. It also signals that the company’s strategic focus on Oracle-led cloud solutions and AI-driven modernization is paying off.

However, the backlog concentration in the UK and Europe also presents geographic risk, especially if macroeconomic conditions tighten. Still, the strong public sector orientation—government and education segments accounted for 39.2% of revenue—provides a degree of stability that many mid-cap peers lack.

What does this backlog growth suggest about Mastek’s future positioning among mid-cap IT players?

The order backlog growth suggests that Mastek is strengthening its position as a niche digital engineering and AI-focused IT services provider. Market observers believe this could help the company achieve above-average revenue growth compared to peers if execution remains steady. If its AI-led initiatives, such as ADOPT.ai and Open Ana partnership-based solutions, continue to scale, Mastek could gradually transition from being a niche mid-cap player to a significant competitor in specialized digital transformation segments.

For FY26, investors will likely monitor whether Mastek can maintain its operating EBITDA margins near the 15% level while executing on its expanding ₹2,347.9 crore order backlog. The company’s ability to balance margin stability with ongoing investments in AI talent and cloud transformation capabilities will be critical in determining its earnings quality over the next few quarters.

Sustained contract wins in healthcare, government, and regulated industries—segments that already account for over 60% of its revenue—could help Mastek remain an outlier among mid-cap IT stocks this financial year. Market observers believe that if execution stays consistent and attrition is contained, Mastek may deliver growth rates ahead of peers like Coforge and Persistent Systems, reinforcing its positioning as a specialized digital engineering and AI transformation player in the mid-cap IT space.